BETHANY SAUL: Open Payments
NPI 1518678945 · MIDDLETOWN, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$682 in 31 payments from 12 companies in 2025. Trend: 2023 $354 · 2024 $741 · 2025 $682
Food & beverage: $581Education: $101
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 8 | $184 |
| Regeneron Healthcare Solutions, Inc. | 9 | $178 |
| Amgen Inc. | 2 | $96 |
| Novartis Pharmaceuticals Corporation | 3 | $76 |
| UCB, Inc. | 1 | $31 |
| GENZYME CORPORATION | 2 | $31 |
| ABBVIE INC. | 1 | $18 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $16 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $14 |
| Janssen Biotech, Inc. | 1 | $14 |
Products named: DUPIXENT, ADBRY, OTEZLA, COSENTYX, ANZUPGO, Bimzelx, SKYRIZI, Winlevi.
Industry payments across RI — which companies pay providers there.
